Gain Therapeutics, Inc. - COM (GANX)

Historical Portfolio Holders from Q1 2021 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
1.86 M
Holdings value Q1 2024
$7.03 M
Value change Q1 2024
+$1.14 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
25
Number of buys Q1 2024
14
Number of sells Q1 2024
-9
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
36269B105
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 1.86 M $7.03 M +$1.14 M $3.77 25
2023 Q4 1.34 M $4.38 M +$110 K $3.27 22
2023 Q3 1.52 M $4.95 M +$797 K $3.28 24
2023 Q2 1.27 M $5.68 M +$521 K $4.48 24
2023 Q1 1.15 M $5.54 M +$289 K $4.82 22
2022 Q4 1.21 M $3.78 M -$19.3 K $3.13 21
2022 Q3 1.21 M $3.95 M +$449 K $3.26 19
2022 Q2 1.07 M $3.87 M -$336 K $3.60 15
2022 Q1 1.15 M $4.71 M +$362 K $4.09 15
2021 Q4 1.05 M $5.7 M +$811 K $5.38 17
2021 Q3 893 K $6.65 M -$472 K $7.45 13
2021 Q2 894 K $8.95 M -$1.89 M $10.00 12
2021 Q1 1.01 M $15 M +$15 M $14.92 12